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A technique commonly employed for preliminary evaluation of cardiovascular and autonomic effects of chemical substances depends upon the use of anesthetized dogs. The compound to be studied is administered intravenously before and after agents of known autonomic activity and effects upon arterial pressure are observed.
Diallylmelamine [2,4-diamino-6-(diallylamino)-s-triazine, U-7720] was tested by this technique on two occasions in preparation for its study in man as a gastric antisecretory agent. In both tests it was inactive. However, when this compound was administered to trained, unanesthetized dogs, it was surprisingly found to have pronounced and prolonged hypotensive activity.
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The present report deseribes some eardiovaseular effeets of this interesting agent when administered aeutely and ehronieally to trained, unanesthetized animals.
Methods
Blooä pressure
Dogs were trained to lie quie$1y on their backs, the femoral artery punctured using a 24 gauge needle, and pressure recorded through a Statham P23g transducer on a Grass Model 5 polygraph. Mean arterial pressure was obtained by electronic damping. All measuremen¢s were made in a sound attenuated room which provided * Presented in part at the 1962 fall meeting of the Ameriean Society for Pharmacology and Experimental Therapeutics in Nashville, Tennessee (FREYBURGER et al. 1962) . ** Present address: Department of Pharmacology, Medical School, University of Michigan, Ann Arbor, Michigan. both isolation and relative freedom from extraneous sounds. Mean blood pressure in rats was measured directly from indwelling aortic cannulas by the method of W~EKS and Jo~¢Es (1960) .
Renal hypertension in dogs was induced by the method of GOLDBLATT et al. (1934) and in rats by the method of GROLLMAN (1944) .
Cardiac Output
The direct Fick method was used on trained unanesthetized dogs in which arterial and venous cannulas (size PE 50 polyethylene tubing) had previously been implanted. Venous blood was obtained from the right ventriele, the eannula being passed down the external jugular vein and its position monitored by pressure pulse tracings on the polygraph. Arterial blood was obtained from a cannula passed down a common carotid into the thoracic aorta. Both catheters were brought subcutaeously to exit through the skin between the shoulder blades. Tubing was anchored in the tissues using flared segments of size PE 100 tubing (HEATLEY and WEEKS 1964) . Blood pressure in these dogs was measured through the aortic cannula. 0xygen contenS was determined using a Natelson micro-gasometer. Blood samples were drawn in oiled syringes and stored in ice (noS over 2 hours) in plastic capped 4 ml vials containing about a 5 mm layer of mercury and filled completely with mineral oil. Small holes in the cap permitted adding of blood samples and displaeement of the mineral oil. Oxygen consumption was measured for aS least five minutes using a Benedict-Roth metabolimeter and a commercial rubber faee-mask for dog use with an anaesthesia machine. Blood samples were drawn during the period oxygen consumption was being measured.
Sympathetic reactivity
The blood pressure rise following bilateral clamping of the common carotid arteries for one minute was used as a measure of sympathetic reactivity. Trained normotensivo dogs with carotid arteries exteriorized in skin tubes according to the teehnique of vA~¢ L]~ERSUM (1911) were used. Blood pressure was recorded continuously by direet femoral artery puncture. ttesults
Blood pressure and heart rate in normotensive dogs
Large single oral doses (25 and 50 mg/kg) of diallylmelamine were given to four unanesthetized normotensive dogs (Table 1) . After a latent period of up to two hours there was a marked tachycardia which persisted for four days, and a disappearance of the normal sinus arrhythmia. Since this is the typical response to vagal blockade in the unanesthetized dog, the possibility that diallylmelamine was an anticholinergie agent was tested by administering small intravenous doses of methacholine chloride (2.5 and 10/~g) to pretreated dogs. While the expeeted brief hypotensive response to methacholine was minimal four to six hours after diallylmelamine, it was essentially normal by the following morning. Thus, the prolonged tachycardia seen in dogs does not reflect classical anticholinergic activity.
The hypotenslve response to diallylmelamine followed the cardioaccelerator effect. It was gradual in onset and maximal between six -1 9 -3 -2 1 3 1 6 -7
-1 3 -1 6 -1 2 -1 5 -1 4 -2 -1 4 -1 9 3 6 -7 -2 7 3 7 -1 7 3 2 2 -4 -2 5 3 4 -1 2 -3 -9 3 2 -1 0 -1 9 3 2 -6 -3 5 3 7 -1 5 -2 5 -1 7 a n d t w e n t y -f o u r h o u r s . S i m f l a r l a t e n t p e r i o d s were n o t e d w h e n t h e e o m p o u n d w a s i n j e c t e d i n t r a v e n o u s l y . N e i t h e r c h a n g e s i n b e h a v i o r o f t h e s e a n i m a l s n e r signs o f t o x i c i t y w e r e o b s e r v e d .
Blood pressure in hypertensive dogs
Dose-response relationships were studied in four renal hypertensive dogs in oral doses ranging from 1 to 10 mg/kg (Table 2) , each dog receiving each dose level, but arranged so that no more than two animals received the same dose in any one week. The latent period noted earlier persisted in the hypertensive animal. Maximum recorded effect was at six hours, although it is likely that the actual peak occurred somewhat later. The 1.0 mg/kg dose appeared to be near threshold.
Blood pressure in unanesthetized rats/ollowing chronic treatment
Diallylmelamine was administered at a dose of 25 mg/kg twice daily for 11 or 12 days to both hypertensive and normotensive rats. Control pressures were measured before starting drug and on the two preceding ,' , HOURS DAYS TIME AFTER FIRST DOSE
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: Fig. 1 . Hypotensivc action of twice daily administration of diallylmclaminc (25 mg/kg) to unanesthctized rats for 11 days. Average initial blood pressure 4-S. E. (each initial the mean of three observations) were: normotensive, 123 :t: 1.6; hypertensive oral group, 175 :t: 6.2; and hypertensive i. p. group, 196 :E 8.6. In the hypertensive oral group, 6/9 rats were treated 12 instead of 11 days, the final pressures for all averaged and plotted between days 11 and 12. In the hypertensive i. p. group, one rat was observed on day 3 instead of 4, this value averaged with other day 4 values; and half the rats were observed on day 7 and the others day 8, the results averaged together and plotted between these 2 days days. Results in Fig. 1 are plotted as mm Hg change from the average initial pressure. For hypertensive rats, blood pressure was measured 1, 4 and 24 hours after the first dose, and then spotted throughout the rest of the test period, each measurement being made before administration of the first dose of the drug for that day (i.e., approximately sixteen hours after dosing). Normotensive rats were treated similarly except that acute observations after 1 and 4 hours were omitted. Maximum decrease in pressure averaged 53 mm Hg (range 31--71) and sustained decrease approximately 25 mm Hg. Orally, in hypertensive rats, there was no marked pressure fall within four hours, but there was a maximum recorded hypotensive effect by the following morning. This effect averaged 37 mm Hg (range 23--57). As the test progressed, pressure came back toward initial values in most of the rats.
In normotensive animals the pressure fall was less marked and was not maintained.
Cardiac output in dogs
The results of cardiac output determinations in trained unanesthetized dogs appear in Table 3 . There was a marked increase, usually a doubling, of cardiae output after diallylmelamine despite the reduced perfusion pressure. This increase persisted for several days following a single dose of the drug. Thus peripheral resistance, expressed as the quotient of mean arteriat pressure and cardiac output, was markedly reduced. The lack of major change in oxygen uptake or in respiratory rate after the drug suggests that the animals were not excited during the drug period.
Since there was a marked tachycardia after diallylmelamine, cardiac output effects were also evaluated during a tachycardia induced by atropine. Data on dog No. 3600 show a similar cardio-acceleration after the atropine without an accompanying cardiac output increase. In this animal, diallylmelamine, administered after atropine, caused a doubling of cardiac output.
To determine whether sympathetic stimulation played a major role in the cardiac output increase, data were obtained in a dog (No. 3827) with thoracic sympathetic supply to the heart surgically extirpated (removal of thoracic sympathetie ganglia down to D-6 bilaterally in two stages, the seeond stage surgery preceding the test period by three weeks). In this animal, diallylmelamine still doubled eardiac output. Thus, the cardiae output increase after this agent was dependent neither upon the aecompanying taehyeardia nor the thoracie sympathetie innervation of the heart.
Sympathetic reactivity
A plot of blood pressure measurements and pressor responses to brief periods of bflateral carotid artery occlusion in dog No. 425 are depicted in Fig. 2 . Results in two other animals were qualitatively the same. The hypotensive effect of diallylmelamine was maximal on the first day with partial recovery as the drug was continued. The pressor response to carotid occlusion was not blocked by the drug, although it m a y have been depressed somewhat initially. I t is concluded that diallylmelamine does not effect significant impairment of sympathetic reactivity as measured by the pressor response to biliteral carotid occlusion.
Sympathetic activity
All four dogs tested experienced a marked fall in mean arterial pressure in response to intravenous tetraethylammonium bromide (TEA) whfle treated with diallylmelamine. When treatment was stopped, the depressor response to TEA was lost gradually over a period of two to four days. Responses to TEA were not obtained during the control period because TEA does not normally have hypotensive activity in unanesthetized dogs lying in the supine position (MAxwELL et al. 1956; FI~EYBU~GER, unpublished) . Fig. 3 is the graph of blood pressure responses to diallylmelamine and to TEA in these dogs. It indicates that this drug does not depress sympathetie vasoconstrictor aetivity. In fact, activity susceptible to blockade by TEA increased significantly, presumably as part of the homeostatic attempt to compensate for the hypotensive action of diallylmelamine.
Since the compound does not lower arterial pressure by effecting a decrease in cardiac output or by suppressing sympathetic activity it is suggested that it has some direct action on resistance vessels and can therefore be termed a vasodilator substance. The mechanism of this vasodilator cffect has not as yet been elucidated.
Diseussion
Arterial pressure is the resultant of delivering a volume of blood (eardiac output) into a reservoir (arterial tree) from which flow is limited by the state of tone in the smaller vessels (peripheral resistance). The foregoing data show diallylmelamine inereases eardiac output. If pressure falls significantly despite an increased output of the heart, peripheral resistance must be decreased markedly. Since sympathetie vasoconstrictor activity appears not to be depressed by this drug, certainly this agent must act to decrease peripheral resistanee by some mechanism other than blockade of sympathetie vasoconstrietor tone. Although such factors as activation of vasodilator nerves or decreasing blood viscosity have not been ruled out, it appears likely that this compound acts directly upon vascular smooth muscle.
The relatively long latent period and relatively poor dose response relationship obtained in the dog suggest that diallylmelamine might not be a hypotensive agent per se but that it might be converted in the body to an active metabolite. This possibility is being investigated.
Summary
Diallylmelamine is an effective hypotensive agent in hypertensive dogs and rats, having a duration of action exceeding twenty-four hours from a single oral dose. It has limited efficacy in normotensive rats. Hypotensive activity of gradual onset is preceded by a latent period of up to two hours and becomes maximal six hours or more after dosing. This agent does not depress cardiac output or sympathetic vasoconstrietor activity. It is suggested that its hypotensive activity results from a direct effect upon vascular smooth muscle.
